FullHope Biomedical Co (ROCO:7773) Change In Inventory: NT$0.48 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7773 FullHope Biomedical Co Ltd ROCO:7773
22 GF Score
Price NT$36.15
! 2 Warning Signs
View Full Analysis

What is FullHope Biomedical Co Change In Inventory?

FullHope Biomedical Co ROCO:7773 +2.84% 22 Change In Inventory is NT$0.48 Mil as of Jun. 2026. GuruFocus rates ROCO:7773 with a GF Score™ of 22/100. The stock has 2 warning signs investors should review.

FullHope Biomedical Co's change in inventory for the quarter that ended in Jun. 2026 was NT$-1.56 Mil. It means FullHope Biomedical Co's inventory increased by NT$1.56 Mil from Dec. 2025 to Jun. 2026 .

FullHope Biomedical Co's change in inventory for the fiscal year that ended in Dec. 2025 was NT$1.82 Mil. It means FullHope Biomedical Co's inventory declined by NT$1.82 Mil from Dec. 2024 to Dec. 2025 .

FullHope Biomedical Co's Total Inventories for the quarter that ended in Jun. 2026 was NT$6.95 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. FullHope Biomedical Co's Days Inventory for the quarter that ended in Jun. 2026 was 220.07.

Inventory Turnover measures how fast the company turns over its inventory within a year. FullHope Biomedical Co's Inventory Turnover for the quarter that ended in Jun. 2026 was 0.83.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. FullHope Biomedical Co's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.29.


FullHope Biomedical Co  (ROCO:7773) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

FullHope Biomedical Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=6.1715/5.118*365 / 2
=220.07

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

FullHope Biomedical Co's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

FullHope Biomedical Co's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FullHope Biomedical Co Change In Inventory Related Terms


FullHope Biomedical Co Change In Inventory Historical Data

* Premium members only.

The historical data trend for FullHope Biomedical Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FullHope Biomedical Co Change In Inventory Chart

FullHope Biomedical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
0.00 -5.52 5.25 -0.66 1.82

FullHope Biomedical Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only -1.06 0.40 -0.21 2.04 -1.56
ROCO:7773
22GF Score
FullHope Biomedical Co Ltd ROCO:7773
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

FullHope Biomedical Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.48 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of NT$0.48 Mil mean?
FullHope Biomedical Co (ROCO:7773) has a Change In Inventory of NT$0.48 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for FullHope Biomedical Co and its competitors.
Is FullHope Biomedical Co's Change In Inventory too high?
FullHope Biomedical Co's current Change In Inventory is NT$0.48 Mil. Overall, FullHope Biomedical Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does FullHope Biomedical Co's Change In Inventory compare to VRTX and REGN?
FullHope Biomedical Co's Change In Inventory of NT$0.48 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for FullHope Biomedical Co and its competitors. FullHope Biomedical Co's current Change In Inventory is NT$0.48 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FullHope Biomedical Co stock overvalued right now?
FullHope Biomedical Co (ROCO:7773) has a current Change In Inventory of NT$0.48 Mil. The current Change In Inventory is NT$0.48 Mil. FullHope Biomedical Co's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For FullHope Biomedical Co (ROCO:7773), the current Change In Inventory is NT$0.48 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

FullHope Biomedical Co Business Description

Address Lane 609, Sector. 5, Chongxin Road, 10th Floor, No. 10, Sanchong District, New Taipei City, TWN
FullHope Biomedical Co Ltd focuses on immune system-related services and innovative R&D. It establishes cell-based immunotherapies for cancers and autoimmune disorders. Its services are, Immunoprofiling, Circulating Tumor Cells Testing, Regulation of Cell Therapy, Contracting Immune Cell Manufacturing, Immune Cell Bank, Contract Research Organization, and Endotoxin and Mycoplasma Detection Service.
22GF Score

Get the complete analysis for ROCO:7773

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$36.15
Price